Navigation Links
Sequenom Announces Preliminary 2013 Operational Highlights And Objectives For 2014
Date:1/12/2014

er of payor contracts, including 2 national payors
  • Receiving reimbursement as an out-of-network laboratory from remaining large commercial payors
  • Medicaid volume was reduced to 14% of accessions in Q4 2013 from 25% in Q1 2013; eight state Medicaid payors are now reimbursing
  • Laboratory location in North Carolina fully operational and currently performing approximately one third of MaterniT21 PLUS tests
  • Mayo Clinic and Sequenom Laboratories partnered to provide access to the MaterniT21 PLUS LDT to the physicians and their patients in the Mayo Clinic network  
  • Massively parallel sequencing (MPS) patent issued in Europe, further strengthening Sequenom's prenatal diagnostic patent portfolio
  • "We overcame many significant challenges in 2013, including the coding changes that resulted in delays or reduced reimbursement by many payors, particularly state Medicaid programs. As we move into 2014, we continue to lead the industry in expanding the use of and reimbursement for noninvasive prenatal testing (NIPT), and continue to work with payors to gain coverage for our tests," said Harry F. Hixson, Jr., Ph.D., Chairman and CEO of Sequenom. "We have set high goals for 2014, and we expect to achieve these goals to continue to build value for our shareholders and maintain our leadership position in NIPT."

    Key Objectives for 2014

    The Company has established its primary financial and R&D objectives for 2014 to include:

    • Achieve quarterly break-even and positive cash flow in Q4 2014
    • Expand the NIPT menu with the development of a low cost test on an alternative platform by year-end, which we expect will facilitate international access and potential future entry into the low-risk market 

    On Thursday, January 16, at 2:00 p
    '/>"/>

    SOURCE Sequenom, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
    2. Sequenom Completes International Distribution Agreements To Expand Access To MaterniT21 PLUS Prenatal Testing Service
    3. Sequenom Welcomes Myla Lai-Goldman, M.D., To Board Of Directors
    4. Sequenom Announces Exercise In Full Of Over-Allotment Option And Completion Of Offering Of $130 Million Of 5.00% Convertible Senior Notes
    5. Sequenom CMMs MaterniT21 PLUS LDT Now Reporting On Gender-Specific Chromosomal Abnormalities
    6. Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2012 Financial Results And Conference Call
    7. Sequenom Announces Participation At The Barclays Global Healthcare Conference
    8. Sequenom, Inc. Reports Financial Results For The Fourth Quarter And Full Year Of 2012
    9. Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
    10. Sequenom Announces Participation At The Bank Of America Merrill Lynch Health Care Conference
    11. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2013
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/26/2015)... VEGAS , March 26, 2015 Zimmer ... Vivacit-E ® Advanced Bearing Technology with ... A paper published earlier this month reported that, ... Vivacit-E Advanced Bearing Technology featuring Vitamin E ... maintained a significant wear rate reduction of 95 percent, ...
    (Date:3/26/2015)... WASHINGTON , March 26, 2015 Even ... anniversary of the Food and Drug Administration,s landmark approval ... from 11 members of Congress calling on the Agency ... approving a first-ever medical treatment for women,s most common ... 26 FDA-approved medical treatment options for sexual dysfunction – ...
    (Date:3/26/2015)... , March 26, 2015 ... and Drug Safety Software Market by Functionality (Adverse Event ... based (SAAS)), End-user (Pharma & Biotech Companies, CROs, ... MarketsandMarkets, the Pharmacovigilance and Drug Safety Software Market ... 6.5% during 2014-2019, and is expected to reach ...
    Breaking Medicine Technology:Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 2Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 3Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 4Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 2Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 3Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 4
    ... a corporate mission of saving 100,000 more lives each year, ... leading manufacturer of medical devices and software for treating cancer ... expand its corporate branding efforts by tapping advertising agency DeVito/Verdi ... will be handled by the New York City-based agency,s San ...
    ... May 9, 2011 NxStage Medical, Inc. (Nasdaq: ... innovative dialysis products, today expressed its support for ... educate U.S. Congressional policymakers and their advisors about ... hemodialysis. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO) On ...
    Cached Medicine Technology:Leading Medical Device and Software Manufacturer Looks to Build Its Brand With DeVito/Verdi 2Leading Medical Device and Software Manufacturer Looks to Build Its Brand With DeVito/Verdi 3NxStage® Supports Initiative by Patient Advocacy Groups to Educate Policymakers about the Benefits of Frequent Home Hemodialysis 2
    (Date:3/26/2015)... (PRWEB) March 26, 2015 Behavioral ... consulting firm, announced the release of BathroomMap® , ... to increase access to public restrooms for travelers, especially ... bathroom apps, BathroomMap does not facilitate a paid, social ... to identify and rate local establishments that have clean, ...
    (Date:3/26/2015)... March 26, 2015 Saving Moses is ... it is most needed but least available. As one ... to six clinics in the Benguela province of Angola ... During a recent visit to their clinics, staff employed ... mothers and their babies in a nation the The ...
    (Date:3/26/2015)... March 26, 2015 The Life ... “Introduction to Hyperbaric Medicine” course, which is accredited ... (UHMS) and the National Board of Diving & ... 40-hour course 4 times a year at several ... NY tri-state region; registration is available on-line at: ...
    (Date:3/26/2015)... March 26, 2015 BioPlus ... leading innovative specialty pharmacies, announces the promotion of ... Vice President of Pharmaceutical Relations. In this position, ... with our pharmaceuticals partners and providing key leadership ... of BioPlus’ expansion. , “Over the past ...
    (Date:3/26/2015)... Md. (PRWEB) March 26, 2015 ... supports the Patients’ Access to Treatments Act (PATA) ... this week by Reps. David B. McKinley (R-WV) ... will limit cost-sharing requirements for medications placed in ... accessible by reducing patients’ out-of-pocket expenses. , This ...
    Breaking Medicine News(10 mins):Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Saving Moses Utilized Photography in an Effort to Engage Mothers and Their Babies on a Recent Visit to Angola 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 3Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 4Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2Health News:Pulmonary Hypertension Association Part of Coalition Supporting the Patients’ Access to Treatments Act 2
    ... Magazine for a poll it was astonishing that Britons were ... 50% of them said that they believe in possessing mind-reading ... 43% said that they could read others' thoughts or had ... they had dreamt of an event before it occurred, 26% ...
    ... Researcher Linda Mansfield Michigan State University is a part ... at the role of parasitic worms// in treatment of ... of a more than $10 million National Institutes of ... Research Network of laboratories launched by the National Institutes ...
    ... Scientists in Japan have developed robotic hands, which they ... ,The artificial hands, developed by Yukiyasu Kamitani and ... based on real-time functional magnetic resonance imaging (fMRI) of ... Scientist. ,Researchers from the ATR Computational Neuroscience ...
    ... Hospital was suspended a she removed the properly functioning kidney ... found him guilty and suspended him for a period of ... that the French surgeon, Mr Blanchard’s conduct was inappropriate, unprofessional ... ,He said that he had not read the ...
    ... services in various hospitals affiliated to GSVM medical college ... against the OBC quota in elite educational institutions entered ... and students were continuing with the protest against Centre's ... in higher centres of learning, representatives of agitating doctors ...
    ... that milk chocolate containing caffeine has been good for ... times. ,Hence, chocolate lovers were found ... ,Adding value to the above study, an under graduate ... Raudenbush, Wheeling Jesuit University has done recently a research, ...
    Cached Medicine News:Health News:Parasitic Worms Could Be Used To Treat Bowel Disease 2
    SHIONORIA BNP,is a reagent used in the measurement of blood BNP. The blood BNP test allows accurate estimation of coronary functions....
    ... assay method for the semi-quantitative determination ... in human serum. The results of ... as an aid in the diagnosis ... associated with elevated anti-neutrophil cytoplasmic antibodies ...
    ... The determination of Ang II ... monitoring the pharmacological effect and ... of angiotensin converting enzyme inhibitors ... receptor antagonists as well as ...
    ... antigen test is a visual ... presumptive qualitative detection of Respitory ... specimens in neonatal and pediatric ... test has a built-in procedural ...
    Medicine Products: